<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02116413</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2013/CR-01</org_study_id>
    <secondary_id>2013-A01702-43</secondary_id>
    <nct_id>NCT02116413</nct_id>
  </id_info>
  <brief_title>Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?</brief_title>
  <acronym>FC-Rev</acronym>
  <official_title>Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate in a population of patients with septic shock
      receiving 500 ml crystalloid over 10 minutes, the proportion of patients classified as
      &quot;responders&quot; to the fluid challenge (increase of at least 15% of ITV in aortic) at the end of
      vascular filling (T10) and becoming &quot;non-responders&quot; 20 minutes after the end of the fluid
      challenge (T30) and whether this proportion is greater than 10 points.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives of this study are :

      A. To assess changes in different ultrasound parameters: E wave , E / A ratio , E / E ' in
      the event of vascular filling and construct a dose response curve for vascular filling.

      B. To determing a threshold value for the mitral E wave velcoity that can predict a positive
      response to volume expansion at T10 defined by a 15% increase in the sub aortic velocity time
      integral (ITV) after 500 ml of crystalloids in 10 minutes.

      C. To determine a threshold value for theITV at T0 that can predict a positive response to
      volume expansion at T10 defined by a 15% increase in the ITV after 500 ml of crystalloids in
      10 minutes.

      D. To evaluate the proportion of responders at T10 becoming non-responders at T20.

      E. To evaluate the proportion of nonresponders at T10 and responders at T30 .

      F. To estimate the proportion of patients changing status regardless of the direction of
      change between T10 and T30 .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Patient status changes from &quot;responder&quot; at the end of the fluid challenge (T10) to &quot;non-responder&quot; 20 minutes after the end of the fluid challenge (T30).</measure>
    <time_frame>30 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>Baseline (minute 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>2 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>4 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>8 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral E wave</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>Baseline (minute 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>2 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>4 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>8 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mitral A wave</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>Baseline (minute 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>2 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>4 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>6 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>8 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>E' Wave at the lateral mitral annulus</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ITV</measure>
    <time_frame>Baseline (minute 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ITV</measure>
    <time_frame>10 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ITV</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ITV</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient status changes from &quot;responder&quot; at the end of the fluid challenge (T10) to &quot;non-responder&quot; 10 minutes after the end of the fluid challenge (T20).</measure>
    <time_frame>20 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient status changes from &quot;non-responder&quot; at the end of the fluid challenge (T10) to &quot;responder&quot; 20 minutes after the end of the fluid challenge (T30).</measure>
    <time_frame>30 minutes</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">145</enrollment>
  <condition>Septic Shock</condition>
  <arm_group>
    <arm_group_label>The study population</arm_group_label>
    <description>The study population consists of patients admitted to intensive care, sedated and under controlled ventilatory support with septic shock criteria defined by severe sepsis associated with hypotension despite fluid resuscitation of 20-40 ml / kg and requiring vascular filling according to the following criteria:
oliguria &lt;0.5 ml / kg / h for at least 2h skin mottling Arterial Lactate &gt; 2 mmol / l SvcO2 &lt;70% or SvO2 &lt;65% Patient on noradrenaline.
Severe sepsis is defined as a systemic inflammatory response associated with a suspected or proven infection and hypotension before filling, a lactate&gt; 4 mmol / l or organ dysfunction.
Intervention: Fluid challenge Intervention: Cardiac ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluid challenge</intervention_name>
    <description>The fluid challenge starts at minute 0 (T0) and consists of 500ml of crystalloids over 10 minutes.</description>
    <arm_group_label>The study population</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac ultrasound</intervention_name>
    <description>Ultrasound measures are made at T0, T2, T4, T6, T8, T10, T20 and T30.</description>
    <arm_group_label>The study population</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of patients admitted to intensive care, sedated and under
        controlled ventilatory support with septic shock criteria defined by severe sepsis
        associated with hypotension despite fluid resuscitation of 20-40 ml / kg and requiring
        vascular filling according to the following criteria:

          -  oliguria &lt;0.5 ml / kg / h for at least 2h

          -  skin mottling

          -  Arterial Lactate &gt; 2 mmol / l

          -  SvcO2 &lt;70% or SvO2 &lt;65%

          -  Patient on noradrenaline.

        Severe sepsis is defined as a systemic inflammatory response associated with a suspected or
        proven infection and hypotension before filling, a lactate&gt; 4 mmol / l or organ
        dysfunction.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient has given his/hers consent or the patient is in an emergency situation
             (commitment to obtain the consent of the patient as soon as his/her condition permits)

          -  Patient affiliated or beneficiary of a health insurance plan

          -  Patient with septic shock: proven or suspected infection associated with hypotension
             or lactate&gt; 4 mmol / l or organ dysfunction. Hypotension despite fluid resuscitation
             of 20 to -40 ml / kg.

          -  Patient under controlled mechanical ventilation

          -  Patient requiring vascular filling according to the following criteria:

          -  oliguria &lt;0.5 ml / kg / h for at least 2h

          -  skin mottling

          -  Arterial Lactate &gt; 2 mmol / l

          -  SvcO2 &lt;70% or SvO2 &lt;65%

          -  Patient on noradrenaline.

        Exclusion Criteria:

          -  The patient is has in another interventional study that might change the results of
             this study within the past 3 months

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient refuses to sign the consent

          -  The patient is pregnant, parturient, or breastfeeding

          -  Valvular pathology: grade III and IV aortic or mitral insufficiency

          -  Non sinus electrocardiogram

          -  Non-echogenic patient

          -  Patient with any spontaneous breathing

          -  Moribund patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Roger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU d'Amiens - Hôpital Nord</name>
      <address>
        <city>Amiens Cedex 1</city>
        <zip>80054</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon - Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Caen - Hôpital Côte de Nacre</name>
      <address>
        <city>Caen Cedex 9</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont Ferrand - Hôpital Estaing</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont Ferrand - Hôpital Gabriel-Montpied</name>
      <address>
        <city>Clermont Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>APHM - Hôpital Nord</name>
      <address>
        <city>Marseille Cedex 20</city>
        <zip>13915</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes - Hôpital Guillaume et René Laennec</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nice - Hôpital St-Roch</name>
      <address>
        <city>Nice Cedex 1</city>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 09</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 15, 2014</study_first_submitted>
  <study_first_submitted_qc>April 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2014</study_first_posted>
  <last_update_submitted>January 18, 2016</last_update_submitted>
  <last_update_submitted_qc>January 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fluid challenge</keyword>
  <keyword>fluid resuscitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

